With these upcoming new launches, Lilly should maintain strong sales and earnings growth for the foreseeable future. The drugmaker's second-quarter revenue was up 38% year over year to $15.6 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback